《大行報告》美銀證券下調快手(01024.HK)目標價至199元 評級「買入」
美銀證券發表研究報告,指快手(01024.HK)第二季用戶增長趨勢見溫和復甦,4月至8月均見回升,預期本地月活躍用戶,以及日均活躍用戶於第三季可錄按季增7%。公司重申長遠日均活躍用戶目標為4億。海外月活躍用戶於第二季達1.8億,至下半年料達2億。
收入方面,公司料下半年行業會有風險,包括廣告需求轉弱。下調2021至23年收入預測5-12%,同時將持續投資內容、增加研發人員、廣告銷售人員、海外員工,以增加推廣和內容開支,調低2021至23年利潤預測,特別是今明兩年,目標價由246元降至199元,維持評級「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.